[go: up one dir, main page]

SG10201600435UA - Vaccines And Compositions Against Streptococcus Pneumoniae - Google Patents

Vaccines And Compositions Against Streptococcus Pneumoniae

Info

Publication number
SG10201600435UA
SG10201600435UA SG10201600435UA SG10201600435UA SG10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA SG 10201600435U A SG10201600435U A SG 10201600435UA
Authority
SG
Singapore
Prior art keywords
vaccines
streptococcus pneumoniae
compositions against
against streptococcus
compositions
Prior art date
Application number
SG10201600435UA
Inventor
Todd Gierahn
Richard Malley
Original Assignee
Genocea Biosciences Inc
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genocea Biosciences Inc, Childrens Medical Center filed Critical Genocea Biosciences Inc
Publication of SG10201600435UA publication Critical patent/SG10201600435UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG10201600435UA 2011-01-20 2012-01-20 Vaccines And Compositions Against Streptococcus Pneumoniae SG10201600435UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161434818P 2011-01-20 2011-01-20

Publications (1)

Publication Number Publication Date
SG10201600435UA true SG10201600435UA (en) 2016-02-26

Family

ID=46516136

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201600435UA SG10201600435UA (en) 2011-01-20 2012-01-20 Vaccines And Compositions Against Streptococcus Pneumoniae
SG2013055496A SG192060A1 (en) 2011-01-20 2012-01-20 Vaccines and compositions against streptococcus pneumoniae

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013055496A SG192060A1 (en) 2011-01-20 2012-01-20 Vaccines and compositions against streptococcus pneumoniae

Country Status (14)

Country Link
US (2) US9393294B2 (en)
EP (1) EP2665490B1 (en)
JP (1) JP6126993B2 (en)
KR (1) KR20140017554A (en)
CN (2) CN105833260A (en)
AU (2) AU2012207089B2 (en)
BR (1) BR112013018642A2 (en)
CA (1) CA2861313A1 (en)
IL (1) IL227554A (en)
MX (1) MX344120B (en)
MY (1) MY163871A (en)
RU (1) RU2623174C2 (en)
SG (2) SG10201600435UA (en)
WO (2) WO2012100234A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107126557A (en) * 2009-06-29 2017-09-05 健诺西生物科学公司 Vaccines and compositions against streptococcus pneumoniae
US20130039947A1 (en) 2010-03-12 2013-02-14 Children's Medical Center Corporation Novel immunogens and methods for discovery and screening thereof
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
AU2013209513B2 (en) * 2012-01-20 2017-10-05 Children's Medical Center Corporation Fused antigen vaccines and compositions against Streptococcus pneumoniae
EP4272750A3 (en) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
US10126305B2 (en) * 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
KR101587859B1 (en) * 2013-09-11 2016-01-25 한국기초과학지원연구원 Composition for diagnosing infection of streptococcus pneumoniae comprising N-aceylglucosamine-6-phosphate deacetylase of streptococcus pneumoniae
JP2017501990A (en) 2013-12-03 2017-01-19 ヴァイロメティックス アーゲー Proline-rich peptide that is protective against S. pneumoniae
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
CN106822885B (en) * 2017-02-16 2020-06-30 清华大学 Streptococcus pneumoniae vaccine
GB201807380D0 (en) * 2018-05-04 2018-06-20 Karlsson Roger Biomarkers for detecting microbial infection
CN112969474A (en) 2018-09-12 2021-06-15 艾芬尼维克斯公司 Multivalent pneumococcal vaccine
RU2701733C1 (en) * 2018-12-14 2019-10-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Live vaccine based on enterococcus faecium l3 probiotic strain for prevention of infection caused by streptococcus pneumonie
US12036276B2 (en) 2021-09-09 2024-07-16 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5371197A (en) 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5474905A (en) * 1993-11-24 1995-12-12 Research Corporation Technologies Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
EP0907738A1 (en) 1996-04-02 1999-04-14 Smithkline Beecham Corporation Novel compounds
AU6909098A (en) 1996-10-31 1998-05-22 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
CA2289116A1 (en) 1997-05-06 1998-11-12 Human Genome Sciences, Inc. Enterococcus faecalis polynucleotides and polypeptides
WO1998059071A1 (en) 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7081530B1 (en) 1997-07-02 2006-07-25 sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en) 1997-07-17 1999-03-16 Smithkline Beecham Corporation Glycogen phosphorylase
US5994101A (en) 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
US6617156B1 (en) 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
EP1144640A3 (en) 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
GB9816337D0 (en) * 1998-07-27 1998-09-23 Cortecs Uk Ltd Proteins
DK1950302T3 (en) * 1998-12-23 2013-01-14 Id Biomedical Corp Quebec Streptococcal antigens.
DE60027890T2 (en) 1999-06-10 2007-04-19 Human Genome Sciences, Inc. STREPTOCOCCUS PNEUMONIAE PROTEINS AND VACCINES
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
NZ519669A (en) 1999-12-23 2004-03-26 Vmax Ltd Streptococcus pyogenes virulence genes and proteins and their use
US6783939B2 (en) 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
EP2277896A1 (en) 2000-10-27 2011-01-26 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups A & B
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP2277897A1 (en) 2001-04-16 2011-01-26 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US20040029129A1 (en) 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7314974B2 (en) 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US20090252756A1 (en) 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
EP1490104B1 (en) 2002-04-02 2012-06-06 Ben-Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
WO2004018646A2 (en) 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
WO2004020609A2 (en) 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
WO2004026256A2 (en) 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
CN102174534A (en) 2003-04-15 2011-09-07 英特塞尔股份公司 S. pneumoniae antigens
GB0318688D0 (en) 2003-08-08 2003-09-10 Chiron Srl Streptococcus pneumoniae knockout mutants
EP1828231A2 (en) 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus
KR20070122458A (en) 2005-02-11 2007-12-31 에이스 바이오사이언시즈 에이/에스 Superficial Streptococcus pneumoniae polypeptide
WO2007106407A2 (en) 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of streptococcus pneumoniae
EP2054431B1 (en) 2006-06-09 2011-08-31 Novartis AG Conformers of bacterial adhesins
GB0700136D0 (en) 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Process for manufacturing vaccines
WO2008119358A2 (en) 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
WO2009011971A2 (en) 2007-05-18 2009-01-22 The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services, Centers For Disease Control And Prevention Primers and probes for the detection of streptococcus pneumoniae
EP2167531B1 (en) 2007-05-25 2012-03-21 Novartis AG Streptococcus pneumoniae pilus antigens
WO2008150885A1 (en) 2007-05-29 2008-12-11 Board Of Regents, The University Of Texas System Modulation of the th-17 cell mediated immune responses
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20100278819A1 (en) 2007-09-14 2010-11-04 Katholieke Universiteit Leuven Streptococcus pneumoniae vaccines
US8466259B2 (en) 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
US7833776B2 (en) 2007-12-12 2010-11-16 National Health Research Institutes Lipidating sequences and use thereof for producing lipidated proteins in E. coli
EA023888B1 (en) 2008-03-14 2016-07-29 Санофи Пастер Байолоджикс, Ллс Replication-defective flavivirus vaccines and vaccine vectors
EP3839512A1 (en) 2008-07-01 2021-06-23 Genocea Biosciences, Inc. Methods of identifying infections and related conditions
KR20110091560A (en) 2008-12-03 2011-08-11 프로테아 벡신 테크놀로지스 엘티디. Glutamyl ptrna synthetase fragments
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
WO2010148496A1 (en) 2009-06-22 2010-12-29 National Health Research Institutes Lipidated tumor- associated antigens and immunotherapeutic compositions
US20120100172A1 (en) 2009-06-25 2012-04-26 Michael Tal Immunogenic streptococcus pneumoniae peptides and peptide-multimers
CN107126557A (en) 2009-06-29 2017-09-05 健诺西生物科学公司 Vaccines and compositions against streptococcus pneumoniae
WO2011064781A1 (en) 2009-11-30 2011-06-03 Ben-Gurion University Of The Negev Research And Development Authority S. pneumoniae adhesins
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (en) 2010-04-06 2012-10-31 株式会社日立製作所 Management method and management apparatus
WO2011128892A2 (en) 2010-04-12 2011-10-20 Protea Vaccine Technologies Ltd. Modified forms of pneumococcal surface immunogenic protein b (psipb)
WO2011141968A1 (en) 2010-05-14 2011-11-17 Hitachi, Ltd. Storage apparatus and data retaining method for storage apparatus
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Also Published As

Publication number Publication date
CN103501809B (en) 2018-08-10
KR20140017554A (en) 2014-02-11
US10188717B2 (en) 2019-01-29
JP2014503002A (en) 2014-02-06
NZ614460A (en) 2015-08-28
MX344120B (en) 2016-12-06
MY163871A (en) 2017-10-31
AU2012207088A1 (en) 2013-05-02
EP2665490B1 (en) 2020-03-04
WO2012100233A1 (en) 2012-07-26
US20170157234A1 (en) 2017-06-08
AU2012207089B2 (en) 2016-04-14
US9393294B2 (en) 2016-07-19
BR112013018642A2 (en) 2019-04-30
IL227554A (en) 2016-10-31
JP6126993B2 (en) 2017-05-10
IL227554A0 (en) 2013-09-30
WO2012100234A1 (en) 2012-07-26
CN103501809A (en) 2014-01-08
EP2665490A4 (en) 2015-07-01
AU2012207089A1 (en) 2013-05-02
CN105833260A (en) 2016-08-10
US20120189649A1 (en) 2012-07-26
RU2013138563A (en) 2015-02-27
EP2665490A1 (en) 2013-11-27
RU2623174C2 (en) 2017-06-22
MX2013008358A (en) 2013-09-02
SG192060A1 (en) 2013-08-30
CA2861313A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
SG10201600435UA (en) Vaccines And Compositions Against Streptococcus Pneumoniae
SG10201403702SA (en) Vaccines and compositions against streptococcus pneumoniae
IL230863A0 (en) Yeast-muc1 immunotherapeutic compositions and uses thereof
HUE047099T2 (en) Antimicrobial compositions and methods employing same
EP2663635A4 (en) Microbial compositions and methods
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
PL3366143T3 (en) Probiotic compositions and methods
IL227896A0 (en) Lyophilized formulations
PH12013500698A1 (en) Hair-mending compositions and associated methods
IL237287A0 (en) Antibody formulations and uses thereof
HUE044521T2 (en) Methods and compositions for watermelon firmness
EP2825196A4 (en) Adjuvant and vaccine compositions
ZA201308537B (en) Vaccine against streptococcus pneumoniae
GB201113770D0 (en) Novel compositions and uses thereof
IL236911A0 (en) Trans-clomiphene formulations and uses thereof
IL234695B (en) Antigenic compositions and methods
IL238532A0 (en) Synbiotic composition and use thereof
GB201315350D0 (en) Methods and compositions
GB201106357D0 (en) Composition and uses thereof
EP2668044A4 (en) Compositions and their use
ZA201304517B (en) Composition for immunization against streptococcus pneumoniae
ZA201308892B (en) Compositions and methods
EP2804627A4 (en) FUSIONED ANTIGENIC VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
GB201315347D0 (en) Methods and compositions
IL238531A0 (en) Synbiotic composition and use thereof